Andrea H. Epperly
Publications by Year
Research Areas
Angiogenesis and VEGF in Cancer, Cancer Treatment and Pharmacology, Cancer Mechanisms and Therapy, PI3K/AKT/mTOR signaling in cancer, HER2/EGFR in Cancer Research
Most-Cited Works
- → Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity(2007)512 cited
- → Discovery of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor(2008)342 cited
- → Discovery and Evaluation of 2-Anilino-5-aryloxazoles as a Novel Class of VEGFR2 Kinase Inhibitors(2005)135 cited
- → The identification of pyrazolo[1,5-a]pyridines as potent p38 kinase inhibitors(2008)43 cited
- → Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models(2004)43 cited
- → Regulation of Ingestive Behaviors in the Rat by GSK1521498, a Novel μ-Opioid Receptor-Selective Inverse Agonist(2011)43 cited
- → Discovery of thiophene inhibitors of polo-like kinase(2008)37 cited
- → Correlation of anti-tumor and anti-angiogenic activity of VEGFR inhibitors with inhibition of VEGFR2 phosphorylation in mice(2005)14 cited
- → Imidazo[5,1-f][1,2,4]triazin-2-amines as novel inhibitors of polo-like kinase 1(2008)12 cited
- → Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitors(2008)11 cited